Best Fit Profiles
- knee osteoarthritis symptom management as adjunct to physical therapy
Joint health and cartilage support
Glucosamine
Glucosamine sulfate has the strongest evidence for knee osteoarthritis symptom reduction. The GAIT trial showed modest benefit; the MOVES trial showed equivalence to celecoxib in some subgroups. Structural modification effects remain debated.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest pain and function improvement in knee osteoarthritis; effect size smaller than NSAIDs but with better safety profile
- Safety
- Low Risk
Shell-derived; shellfish allergy is a contraindication for some products. Mild GI effects. Crystalline glucosamine sulfate outperforms hydrochloride form in trials.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 1500 mg (sulfate form)
- Timing
- With meals, single or split dose
- Protocol Duration in Studies
- Minimum 8-12 weeks for symptom assessment; ongoing for joint support
Glucosamine sulfate is significantly better-evidenced than glucosamine HCl; form matters.